Compare Nuwellis Inc (NUWE) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Payoneer Global Inc — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Payoneer Global Inc trades at $7.11 (market cap $2.42B). The key difference: Payoneer Global Inc is far larger — about 968× Nuwellis Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | PAYO | |
|---|---|---|
Market Cap | $2.50M | $2.42B |
Sector | Technology | Technology |
52-Week High | $164.50 | $7.18 |
52-Week Low | $0.73 | $4.27 |
Enterprise Value | -$1.21M | $2.16B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Payoneer Global (PAYO) trades at $7.13, down 0.56% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company reported Q2 2026 earnings of $0.02 per share, missing estimates, but revenue grew 10% year-over-year excluding interest. A pending acquisition by Nuvei for $7.40 per share announced in June 2026 is a key catalyst, though legal investigations question the deal's fairness.
The outlook hinges on the acquisition closing, offering a slight premium to current price, but execution risks and earnings volatility pose concerns. Analysts maintain a 60% buy rating, seeing value in cross-border payment growth, yet margin pressures and integration challenges post-acquisition are key investor risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
